Quick Answer
INTERPACE BIOSCIENCES, INC. reported Operating Income Loss of $4.08 million for the year ending 2025.
- INTERPACE BIOSCIENCES, INC. showed a decrease of -49.6% in Operating Income Loss from 2024 to 2025.
- This data is from INTERPACE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: -$316.0 thousand | Q3 2012: -$756.0 thousand | Q1 2013: $2.25 million | Q2 2013: -$847.0 thousand | Q3 2013: -$2.05 million | Q1 2014: -$414.0 thousand | Q2 2014: -$1.06 million | Q3 2014: -$3.20 million | Q1 2015: -$6.12 million | Q2 2015: -$7.71 million | Q3 2015: -$6.65 million | Q1 2016: -$3.80 million | Q2 2016: -$2.89 million | Q3 2016: -$6.49 million | Q1 2017: $3.70 million | Q2 2017: -$3.60 million | Q3 2017: -$3.10 million | Q1 2018: -$3.25 million | Q2 2018: -$1.90 million | Q3 2018: -$2.47 million | Q1 2019: -$3.28 million | Q2 2019: -$5.26 million | Q3 2019: -$7.13 million | Q1 2020: -$6.35 million | Q2 2020: -$5.77 million | Q3 2020: -$6.01 million | Q1 2021: -$3.82 million | Q2 2021: -$2.91 million | Q3 2021: -$1.83 million | Q1 2022: -$977.0 thousand | Q2 2022: -$1.91 million | Q3 2022: -$780.0 thousand | Q1 2023: $838.0 thousand | Q2 2023: $1.22 million | Q3 2023: $412.0 thousand | Q1 2024: $1.11 million | Q2 2024: $2.63 million | Q3 2024: $2.30 million | Q1 2025: $1.83 million | Q2 2025: -$468.0 thousand | Q3 2025: $1.15 million.
- Over the full 16 years of available data (2010 to 2025), INTERPACE BIOSCIENCES, INC.'s Operating Income Loss has grown by 159.2%.
- Historical annual values: Fiscal year 2025: $4.08 million | Fiscal year 2024: $8.11 million | Fiscal year 2023: $3.96 million | Fiscal year 2022: -$3.62 million | Fiscal year 2021: -$6.34 million | Fiscal year 2020: -$26.07 million | Fiscal year 2019: -$26.44 million | Fiscal year 2018: -$12.12 million | Fiscal year 2017: -$6.29 million | Fiscal year 2016: -$6.44 million | Fiscal year 2015: -$40.41 million | Fiscal year 2014: -$17.83 million | Fiscal year 2013: -$1.44 million | Fiscal year 2012: -$25.23 million | Fiscal year 2011: -$4.70 million | Fiscal year 2010: -$6.90 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: